Martin Vazquez - Apr 1, 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
Chief Operating Officer
Signature
By: John L Brottem For: Martin Vazquez
Stock symbol
OM
Transactions as of
Apr 1, 2022
Transactions value $
-$837,851
Form type
4
Date filed
4/4/2022, 05:15 PM
Previous filing
Mar 16, 2022
Next filing
May 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $25.9K +6.67K +13.47% $3.88* 56.2K Apr 1, 2022 Direct
transaction OM Common Stock Sale -$305K -6.67K -11.87% $45.81 49.5K Apr 1, 2022 Direct F1, F2
transaction OM Common Stock Options Exercise $25.2K +6.5K +13.13% $3.88* 56K Apr 1, 2022 Direct
transaction OM Common Stock Sale -$297K -6.5K -11.61% $45.74 49.5K Apr 1, 2022 Direct F1, F3
transaction OM Common Stock Options Exercise $25.2K +6.5K +13.13% $3.88* 56K Apr 1, 2022 Direct
transaction OM Common Stock Sale -$297K -6.5K -11.61% $45.77 49.5K Apr 1, 2022 Direct F1, F4
transaction OM Common Stock Options Exercise $1.29K +332 +0.67% $3.88* 49.8K Apr 1, 2022 Direct
transaction OM Common Stock Sale -$15.2K -332 -0.67% $45.81 49.5K Apr 1, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -332 -1.74% $0.00 18.7K Apr 1, 2022 Common Stock 332 $3.88 Direct F5
transaction OM Performance Options (right to buy) Options Exercise $0 -6.67K -4.84% $0.00 131K Apr 1, 2022 Common Stock 6.67K $3.88 Direct F6
transaction OM Performance Options (right to buy) Options Exercise $0 -6.5K -4.96% $0.00 125K Apr 1, 2022 Common Stock 6.5K $3.88 Direct F6
transaction OM Performance Options (right to buy) Options Exercise $0 -6.5K -5.22% $0.00 118K Apr 1, 2022 Common Stock 6.5K $3.88 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $44.00-$44.99 - 200 shares; $45.00-$45.99 - 4,890 shares; $46.00 - $46.99 - 1,910 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $44.00-$44.99 - 100 shares; $45.00-$45.99 - 4,985 shares; $46.00 - $46.99 - 1,415 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 5,012 shares; $46.00 - $46.99 - 1,488 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
F6 This option vests if and to the extent that (i) the sum of (A) the 30-day closing price of one Share and (B) the Aggregate Cash Distributions is equal to or greater than $20.46 (reduced to $19.12 in 2020) on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to one greater than $20.46 (increased to $20.86 in 2020) as of the effective date of such Corporate Event.